Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Tomonori Kobayakawa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tomonori Ishii < Tomonori Kobayakawa < Tomonori Ogura  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000509 (2019) Shuji Asai [Japon] ; Masatoshi Hayashi [Japon] ; Masahiro Hanabayashi [Japon] ; Yasuhide Kanayama [Japon] ; Toki Takemoto [Japon] ; Yuichiro Yabe [Japon] ; Tomone Shioura [Japon] ; Hisato Ishikawa [Japon] ; Yutaka Yoshioka [Japon] ; Takefumi Kato [Japon] ; Yuji Hirano [Japon] ; Takayoshi Fujibayashi [Japon] ; Yosuke Hattori [Japon] ; Tomonori Kobayakawa [Japon] ; Masahiko Ando [Japon] ; Yachiyo Kuwatsuka [Japon] ; Nobunori Takahashi [Japon] ; Takuya Matsumoto [Japon] ; Nobuyuki Asai [Japon] ; Yasumori Sobue [Japon] ; Tsuyoshi Nishiume [Japon] ; Mochihito Suzuki [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study.
001141 (2015) Tomonori Kobayakawa ; Toshihisa Kojima ; Nobunori Takahashi ; Masatoshi Hayashi ; Yuichiro Yabe ; Atsushi Kaneko ; Tomone Shioura ; Kiwamu Saito ; Yuji Hirano ; Yasuhide Kanayama ; Hiroyuki Miyake ; Nobuyuki Asai ; Koji Funahashi ; Shinya Hirabara ; Masahiro Hanabayashi ; Shuji Asai ; Naoki IshiguroDrug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.
001634 (2013) Yuichiro Yabe [Japon] ; Toshihisa Kojima ; Atsushi Kaneko ; Nobuyuki Asai ; Tomonori Kobayakawa ; Naoki IshiguroA review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Tomonori Kobayakawa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Tomonori Kobayakawa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Tomonori Kobayakawa
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021